C-Semaglutide 5mg/mL injection — Class II drug recall D-0538-2023
Ongoing recall by Pharmacy Plus, Inc. dba Vital Care Compounder, reported 2023-04-26. Lack of assurance of sterility.
| Recall number | D-0538-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Pharmacy Plus, Inc. dba Vital Care Compounder, Hattiesburg, MS, United States |
| Recall initiated | 2023-04-13 |
| Classified | 2023-04-19 |
| Reported by FDA | 2023-04-26 |
| Quantity | 45 vials |
| Reason classes | sterility |
| Lot numbers | 73810 |
| Expiration dates | 2023-05-01 |
Product
C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 South 40th Ave, Suite A Hattiesburg, MS 39402
Reason for recall
Lack of assurance of sterility.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0538-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.